Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
Dr. Lorenzo Tibaldi joined Enterome in 2016, to lead drug and biomarker discovery projects focused on the identification of microbiome-related compounds and targets for future applications in immuno-oncology. At Enterome, Lorenzo supervises a research group involved in the screening and discovery of microbial compounds as novel immunomodulators.
Lorenzo obtained his Ph.D. from University Pierre et Marie Curie in Paris, followed by a postdoctoral training at Institut Curie (Paris, France). During his career Lorenzo worked on several discovery projects focused on different aspects of immuno-oncology: monoclonal antibody development, biomarker identification, and development of cellular immunotherapies (CAR-T cells) in both biotech and academia